MRP-63 inhibitors represent a class of chemical compounds distinguished by their ability to modulate the activity of the MRP-63 protein, a molecular entity involved in various cellular processes. These inhibitors are characterized by their specific interaction with the MRP-63 protein, targeting its active site or other critical regions essential for its function. The design and development of MRP-63 inhibitors involve sophisticated chemical synthesis and molecular modeling techniques, aiming to achieve high specificity and efficacy. Researchers employ advanced computational tools to predict the interaction between these inhibitors and the MRP-63 protein, optimizing the chemical structure of these compounds to enhance their binding affinity. This process involves iterative cycles of design, synthesis, and testing to identify compounds with optimal characteristics.
The study of MRP-63 inhibitors is grounded in a comprehensive understanding of the protein's structure and function. By elucidating the three-dimensional structure of MRP-63, scientists can identify binding sites for inhibitors and understand the molecular basis of the protein's activity. Laboratory experiments, including X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy, provide detailed insights into the interaction between MRP-63 and its inhibitors. These studies are complemented by biochemical assays to assess the inhibitory effect of candidate compounds on MRP-63 activity, allowing for the quantitative evaluation of their efficacy. Overall, the research on MRP-63 inhibitors is a multidisciplinary effort that integrates chemical synthesis, structural biology and computational chemistry to develop compounds that can modulate the activity of the MRP-63 protein effectively.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chloramphenicol | 56-75-7 | sc-3594 | 25 g | $90.00 | 10 | |
Inhibits mitochondrial protein synthesis, potentially impacting MRP-63 function. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Another inhibitor of mitochondrial protein synthesis, could indirectly affect MRP-63. | ||||||
Erythromycin | 114-07-8 | sc-204742 sc-204742A sc-204742B sc-204742C | 5 g 25 g 100 g 1 kg | $57.00 $245.00 $831.00 $1331.00 | 4 | |
Inhibits bacterial ribosomes, which are structurally similar to mitochondrial ribosomes, potentially affecting MRP-63. | ||||||
Azithromycin | 83905-01-5 | sc-254949 sc-254949A sc-254949B sc-254949C sc-254949D | 25 mg 50 mg 500 mg 1 g 5 g | $52.00 $103.00 $260.00 $364.00 $728.00 | 17 | |
Inhibits bacterial protein synthesis, could have indirect effects on mitochondrial ribosomes and MRP-63. | ||||||
Doxycycline-d6 | 564-25-0 unlabeled | sc-218274 | 1 mg | $16500.00 | ||
A tetracycline antibiotic, could affect mitochondrial protein synthesis and MRP-63 function. | ||||||
Clarithromycin | 81103-11-9 | sc-205634 sc-205634A | 100 mg 250 mg | $77.00 $122.00 | 1 | |
Inhibits protein synthesis in bacteria, potentially affecting MRP-63 in mitochondria. | ||||||
Roxithromycin | 80214-83-1 | sc-205845 sc-205845A | 1 g 5 g | $52.00 $156.00 | ||
A macrolide antibiotic, might impact mitochondrial ribosomal function involving MRP-63. | ||||||
Fusidic acid | 6990-06-3 | sc-215065 | 1 g | $292.00 | ||
Inhibits protein synthesis, could indirectly affect MRP-63's role in mitochondria. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $166.00 $322.00 | 436 | |
Causes premature chain termination during protein synthesis, potentially impacting MRP-63. | ||||||